JXFG.F logo

Jinxin Fertility Group OTCPK:JXFG.F Stock Report

Last Price

US$0.20

Market Cap

US$1.1b

7D

0%

1Y

n/a

Updated

13 May, 2024

Data

Company Financials +

Jinxin Fertility Group Limited

OTCPK:JXFG.F Stock Report

Market Cap: US$1.1b

JXFG.F Stock Overview

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States.

JXFG.F fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance4/6
Financial Health3/6
Dividends3/6

Jinxin Fertility Group Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Jinxin Fertility Group
Historical stock prices
Current Share PriceHK$0.20
52 Week HighHK$0.50
52 Week LowHK$0.20
Beta1.4
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-92.41%

Recent News & Updates

Recent updates

Shareholder Returns

JXFG.FUS HealthcareUS Market
7D0%2.6%0.6%
1Yn/a4.4%25.7%

Return vs Industry: Insufficient data to determine how JXFG.F performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how JXFG.F performed against the US Market.

Price Volatility

Is JXFG.F's price volatile compared to industry and market?
JXFG.F volatility
JXFG.F Average Weekly Movementn/a
Healthcare Industry Average Movement7.7%
Market Average Movement6.1%
10% most volatile stocks in US Market16.4%
10% least volatile stocks in US Market2.9%

Stable Share Price: JXFG.F's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine JXFG.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19513,273Yang Dongwww.jxr-fertility.com

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS.

Jinxin Fertility Group Limited Fundamentals Summary

How do Jinxin Fertility Group's earnings and revenue compare to its market cap?
JXFG.F fundamental statistics
Market capUS$1.07b
Earnings (TTM)US$47.70m
Revenue (TTM)US$385.93m

22.4x

P/E Ratio

2.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
JXFG.F income statement (TTM)
RevenueCN¥2.79b
Cost of RevenueCN¥1.61b
Gross ProfitCN¥1.18b
Other ExpensesCN¥830.72m
EarningsCN¥344.72m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.13
Gross Margin42.15%
Net Profit Margin12.36%
Debt/Equity Ratio23.2%

How did JXFG.F perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

42%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.